Drug Shortage Report for GENTAMICIN(E)

Last updated on 2019-11-19 History
Report ID 95567
Drug Identification Number 02082136
Brand name GENTAMICIN(E)
Common or Proper name GENTAMICIN(E)
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) GENTAMICIN
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 100 mL (JB0863)
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-10-04
Actual start date 2019-10-04
Estimated end date 2019-11-18
Actual end date 2019-11-18
Shortage status Resolved
Updated date 2019-11-19
Company comments Short-dated product with November 2019 expiry available with approval provided. For questions or concerns contact Baxter customer care (1.888.719.9955).
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2019-11-19 English Compare
v9 2019-11-18 French Compare
v8 2019-11-18 English Compare
v7 2019-11-16 French Compare
v6 2019-11-16 English Compare
v5 2019-10-30 French Compare
v4 2019-10-30 English Compare
v3 2019-10-05 English Compare
v2 2019-10-04 French Compare
v1 2019-10-04 English Compare

Showing 1 to 10 of 10